NPI: 1558325696 · EMPORIA, VA 23847 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/14/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/14/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 21,845 | $140K |
| 2019 | 24,094 | $313K |
| 2020 | 20,077 | $482K |
| 2021 | 18,491 | $501K |
| 2022 | 14,347 | $506K |
| 2023 | 6,114 | $266K |
| 2024 | 2,042 | $90K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 35,534 | 2,289 | $2.26M |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 750 | 383 | $14K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 28,534 | 1,226 | $10K |
| A4657 | Syringe, with or without needle, each | 6,154 | 1,748 | $6K |
| J1270 | Injection, doxercalciferol, 1 mcg | 22,085 | 1,391 | $3K |
| J1756 | Injection, iron sucrose, 1 mg | 7,336 | 1,434 | $3K |
| G0008 | Administration of influenza virus vaccine | 100 | 73 | $273.04 |
| 83970 | 1,094 | 589 | $163.88 | |
| 90674 | 37 | 28 | $124.22 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 192 | 83 | $49.81 |
| 82728 | 680 | 371 | $39.63 | |
| 85041 | 1,630 | 875 | $26.34 | |
| 83550 | 656 | 357 | $23.16 | |
| 85048 | 1,547 | 842 | $20.00 | |
| 83540 | 659 | 359 | $17.16 | |
| 90662 | 22 | 12 | $0.00 |